J A Sacristán
J A Sacristán publishes mostly in Psychiatry and Mental health, Economics and Econometrics and Pharmacology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Schizophrenia research and treatment and Electroconvulsive Therapy Studies.
- World rank
- #5,124,780 of 7,710,434 ranked researchers
- Rank in Spain
- #119,751 of 204,306
- Works
- 47
- Citations
- 621
- Citations per work
- 13.2
What does J A Sacristán research?
J A Sacristán's work is mostly in Medicine (22%), Economics, Econometrics and Finance (11%), Pharmacology, Toxicology and Pharmaceutics (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2756.5%
- Health Sciences1327.3%
- Medicine1022.2%
- Health Professions25.1%
- Social Sciences511.1%
- Life Sciences25.1%
- 1Psychiatry and Mental health14% of their works
- 2Economics and Econometrics11% of their works
- 3Pharmacology5% of their works
- 4General Health Professions5% of their works
- 5Pharmacology5% of their works
- 6Emergency Medicine3% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Schizophrenia research and treatment
- Electroconvulsive Therapy Studies
- Pharmaceutical Practices and Patient Outcomes
- Blood disorders and treatments
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Analytical Methods in Pharmaceuticals
Which keywords describe J A Sacristán's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Antipsychotic Drugs, Neurocognitive Deficits, Electroconvulsive Therapy, Serotonin Syndrome, Inappropriate Medication Use and Polypharmacy.
- Pharmacogenetics
- Neutropenia
- Green Analytical Chemistry
- Drug-Induced Liver Injury
- Polypharmacy
- Serotonin Syndrome
- Neurocognitive Deficits
- Quality of Life
- Cost-effectiveness Analysis
- Antipsychotic Drugs
- Electroconvulsive Therapy
- Inappropriate Medication Use
- Cytochrome P450
- Genetic Mutations
- Hepatotoxicity
- Pharmaceutical Analysis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Cost-effectiveness Analysis81 topic
- Quality of Life81 topic
- Antipsychotic Drugs71 topic
- Neurocognitive Deficits71 topic
- Electroconvulsive Therapy41 topic
- Serotonin Syndrome41 topic
- Inappropriate Medication Use31 topic
- Polypharmacy31 topic
- Cytochrome P45021 topic
- Drug-Induced Liver Injury21 topic
- Genetic Mutations21 topic
- Green Analytical Chemistry21 topic
- Hepatotoxicity21 topic
- Neutropenia21 topic
- Pharmaceutical Analysis21 topic
- Pharmacogenetics21 topic
Where does J A Sacristán work?
J A Sacristán's main affiliation in the publication record is Eli Lilly (Spain), Spain.
How many publications and citations does J A Sacristán have?
OpenAlex counts 47 works and 621 citations for J A Sacristán, an h-index of 9, ranking #5,124,780 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about J A Sacristán. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.